Page 188 - CW E-Magazine (17-10-2023)

Special Report

rials and extracted from either lanolin or delivery systems for complex therapeu- 5. Cheng, X. and Lee, R.J., 2016.
animal tissues. Plant-based cholesterol tic drugs and in next-generation mRNA The role of helper lipids in lipid
eliminates the impurities and potential vaccines, supported by a vast portfolio nanoparticles (LNPs) designed for
contamination associated with animal- of phospholipids, cationic lipids, PEG oligonucleotide delivery. Advan-
based cholesterol and can address lipid lipids, sterols, and more. ced drug delivery reviews, 99,
shortages in vaccine production. Avanti, pp.129-137.
now part of Croda Pharma, supplies REFERENCES 6. Bae, Y.U., Huh, J.W., Kim, B.K.,
pure, plant-based parenteral cholesterol 1. Shrestha, H., Bala, R. and Arora, Park, H.Y., Seu,Y.B. and Doh,
that meets USP-NF, Ph. Eur. (2397) and S., 2014. Lipid-based drug deli- K.O., 2016. Enhancement of lipo-
JP pharmaceutical specifi cations. The very systems. Journal of pharma- some mediated gene transfer by
parenteral grade plant-based choles- ceutics, 2014. adding cholesterol and cholesterol
terol can be used as a high-purity alter- 2. Chime, S.A. and Onyishi, I.V., modulating drugs. Biochimica et
native to traditional egg- and animal- 2013. Lipid-based drug delivery Biophysica Acta (BBA)-Biomem-
based cholesterol. Acting as a stability systems (LDDS): Recent advances branes, 1858(12), pp.3017-3023.
enhancer and assisting in the transfec- and applications of lipids in drug 7. Morein, B. and Bengtsson, K.L.,
tion of nucleic acids, it is available for delivery. Afr. J. Pharm. Pharmacol, 1999. Immunomodulation by is
both R&D work and parenteral appli- 7(48), pp.3034-3059. coms, immune stimulating com-
cations. 3. Zhang, X., Barraza, K.M. and plexes. Methods, 19(1), pp.94-102.
Beauchamp, J.L.,2018. Choles- 8. Lövgren Bengtsson, K., Morein,
A long-term lipid innovations partner terol provides non sacrifi cial pro- B. and Osterhaus, A.D., 2011. IS-
Croda Pharma offers its innovative tection of membrane lipids from COM technology-based Matrix
Avanti lipids portfolio in both research chemical damage at air-water inter- M™ adjuvant: success in future
and GMP grades. This expanded capa- face. Proceedings of the National vaccine srelies on formulation.
bility follows Croda’s acquisition of Academy of Sciences, 115 (13), Expert review of vaccines, 10(4),
Avanti Polar Lipids, a leading partner pp.3255-3260. pp.401-403.
for the development and formulation of 4. Raffy, S. and Teissie, J., 1999. Con- 9. Pearse, M.J. and Drane, D., 2005.
lipid technologies to address key formu- trol of lipid membrane stability by ISCOMATRIX® adjuvant for anti-
lation challenges. Croda’s high-purity cholesterol content. Biophysical gen delivery. Advanced drug deli-
lipids and excipients can be utilised in journal, 76(4), pp.2072-2080. very reviews, 57(3), pp.465-474.

Target Your Market More Effectively

IndiaChemTrade
Free for subscribers of Chemical Weekly
IndiaChemTrade provides consolidated trade statistics of India. The information provided here is based on
the annual trade data published by the Directorate General of Commercial Intelligence and Statistics, Govern-
ment of India. The database can be searched by: Chemical Name/Harmonised Code to obtain the consolidated
trade (import or export) in that item; or by Country to obtain the trade (import or export) in all chemicals and
related products between India and that country.

ChemXchange

Open to all – no subscription required
ChemXchange – the chemical exchange with a difference – is where you can identify your buyers and supply-
ers on-line, any time. Listing in this unique platform is free to all advertisers in the print version of Chemical
Weekly for a period of 12 months.

For more information contact: 022-24044471 / 72
Email: corporate@chemicalweekly.com or log on to chemicalweekly.com

188 Chemical Weekly October 17, 2023

Contents Index to Advertisers Index to Products Advertised